A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Status:
Completed
Trial end date:
2017-10-17
Target enrollment:
Participant gender:
Summary
The purpose of this Phase I study is to determine the safety of a drug called dexmedetomidine
(DEX) as part of a balanced general anesthetic and sedative strategy for neonates and infants
undergoing corrective cardiac surgery that requires the use of cardiopulmonary bypass for
congenital cardiac problems. This study will also design and validate a dosing schema for the
use of DEX as described above.